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Dialyzer membrane type and reuse practice influence polymor-
phonuclear leukocyte function in hemodialysis patients.
Background. Polymorphonuclear leukocyte (PMNL) pro-
duction of reactive oxygen species (ROS) has been linked to
hemodialysis (HD) associated morbidity. The effect of dialyzer
membrane type and reuse on PMNL function has not been
clearly defined.
Methods. The present report is a cross-sectional study un-
dertaken in a cohort of patients undergoing regular HD, at
enrollment into the Hemodialysis (HEMO) Study, to study
the association between patient and dialysis-related factors and
PMNL function. PMNL function was assessed by measuring
PMA- and N-formyl methionyl-leucyl-phenylalanine (fMLP)
-induced respiratory burst, and phagocytic activity toward
Staphylococcus aureus.
Results. PMNL from patients dialyzed with polysulphone
(PS) or cuprophane (CU) membranes showed higher PMA-
induced respiratory burst activity compared with those exposed
to substituted cellulose (cellulose acetate, cellulose triacetate,
CA/CT) membranes, regardless of dialyzer reuse. The use of
bleach as a cleansing agent during reuse was associated with
higher PMA-induced PMNL superoxide production, as was the
use of renalin when compared to aldehydes. In a subgroup
of patients using PS dialyzers, reuse itself was associated
with higher fMLP-induced superoxide production. The type
of bleach-germicide combination during reuse showed that
use of renalin as a germicide was also associated with higher
PMNL phagocytosis index. The number of years on HD cor-
related inversely with PMA-induced PMNL superoxide re-
sponse. Weaker PMNL response to fMLP was associated with
greater comorbidity and poor functional status as quantified by
Index of Coexisting Diseases (ICED) and Karnofsky scores,
respectively.
Conclusion. Our results indicate that dialyzer membrane
type and the reuse process influence the oxidative response of
PMNL among HD patients. The implications of these obser-
vations on clinical morbidity need to be further evaluated in
prospective studies.
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Polymorphonuclear leukocyte (PMNL) function
among patients on long-term hemodialysis (HD) has
been an important focus of study over the past two
decades. Clinical correlates of depressed PMNL function
have been associated with increased risk of infections
and infectious mortality in HD patients [1, 2]. However,
heightened phagocyte activation, generation of reactive
oxygen species (ROS), and consequent oxidative stress
have more recently been linked to complications such as
accelerated atherosclerosis [3], malnutrition and inflam-
mation [4, 5], and the deleterious effects of homocysteine
on vascular endothelium [6].
Previous work in this area has addressed the effect of
uremia [7, 8] and acute intradialytic blood-membrane in-
teractions [8, 9] on PMNL function. Phagocytic cell func-
tion has also been used as an index of biocompatibility
[10]. Indeed, the metabolic response to phagocytosis was
demonstrated to be significantly lower in uremic patients
compared to controls, and declined further on initiation
of dialysis with complement-activating membranes [11].
Thus, the relationship between PMNL function, clinical,
and dialysis-related variables is a dynamic one that merits
further exploration. There has been no systematic study
on a larger scale to identify the determinants of, and clini-
cal significance of, PMNL function parameters in patients
on long-term maintenance HD. In particular, the rela-
tionship of PMNL function to dialyzer membrane type,
reuse-related variables, demographic characteristics, or
indices of comorbidity has not been clearly defined. In
the present study, PMNL respiratory burst and phagocy-
tosis were measured in a cohort of patients undergoing
maintenance HD, at enrollment into the Hemodialysis
(HEMO) Study, before randomization into study limbs
took place. Patient- and HD-related factors associated
with PMNL function were identified.
METHODS
Patient enrollment and characteristics
The study population included adult patients (18–80
years old) who had completed a minimum of 3 months on
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maintenance HD three times a week, who were enrolled
into the baseline phase of the HEMO Study from the
dialysis units affiliated with the two participating Boston
centers. This ancillary study was approved by the Human
Investigation Review Committee (HIRC), and all partic-
ipants provided written, informed consent. The HEMO
Study was sponsored by the United States National Insti-
tute of Diabetes, Digestive, and Kidney Diseases, and the
full-scale trial began in 1995. Details regarding the design
of the HEMO Study have been published elsewhere [12].
In brief, this was a multicenter, prospective, randomized
clinical trial designed to evaluate the effect of dialyzer
urea and b2-microglobulin clearances on the morbidity
and mortality of patients. The following were exclusion
criteria: patients in acute care or chronic care hospitals;
interdialytic urea clearance >1.5 mL/min; pregnancy;
scheduled living related renal transplant; <6 months after
failed renal transplant; active malignancy; severe cardiac,
pulmonary, or liver disease; serum albumin <3.0 g/dL;
participation in ongoing investigational drug/device stud-
ies; or inability to participate due to incompetence, re-
fusal, or likelihood of geographic move.
Heparinized blood samples were collected from these
patients upon enrollment in the HEMO Study. Demo-
graphic, clinical, laboratory, and hemodialysis-related
data were provided by the HEMO Study Data Coordi-
nating Center at Cleveland, Ohio, and consisted of base-
line information collected at enrollment. Clinical data
included comorbidity parameters [derived index of co-
existent disease (ICED) scores] [13, 14], nutritional in-
dices [body mass index (BMI), serum albumin] [15], and
functional status (Karnofsky index) [16]. Hemodialysis-
related variables included dialysis adequacy data, type of
dialyser used, presence and type of reuse procedure, and
number of years on dialysis, and again referred to the
dialysis parameters identified at enrollment and before
randomization.
PMNL function parameters
Baseline PMNL function was assessed upon enroll-
ment in the HEMO Study. The production of ROS by
PMNL after stimulation by phorbol myristate acetate
(PMA) or N-formyl methionyl–leucyl–phenylalanine
(fMLP) was assessed. In addition, the ability of PMNL
to phagocytose Staphylococcus aureus was measured.
Measurements of ROS production after stimulation with
PMA and fMLP were also carried out in PMNLs har-
vested from 10 healthy volunteers. PMA is a pharma-
cologic activator of protein kinase C that leads to the
phosphorylation of several substrates including p47phox,
which are critical in NADPH-oxidase activation and gen-
eration of the neutrophil respiratory burst. FMLP, on the
other hand, binds to a G-protein coupled receptor, even-
tually triggering NADPH-oxidase activation [17].
PMNL isolation
Heparinized (10 IU/mL) whole blood was drawn from
the fistula needle before the start of dialysis for harvesting
PMNL and transported on ice within an hour of collection
to the laboratory for processing. Water and other solu-
tions used in the study were subjected to ultrafiltration us-
ing a polyamide hollow-fiber ultra-filter (U2000; Gambro
AB, Hechingen, Germany) to remove cytokine-inducing
agents. The buffy coat was separated using the Ficoll-
Hypaque density gradient separation technique [18]. Ten
mL of heparinized blood was diluted in 20 mL of normal
saline (Abbott Laboratories, Rockford, IL, USA), under-
layered with 10 mL of Ficoll-Hypaque (Sigma Chemical
Co., St. Louis, MO, USA; Nycomed Inc., New York, NY,
USA), and centrifuged at 1200 rpm for 45 minutes at
room temperature. The buffy coat was harvested and re-
suspended in 25 mL of Dulbecco’s phosphate-buffered
saline (PBS) (Gibco BRL-Life Technologies, Grand Is-
land, NY, USA), and 3% dextran (Sigma Chemical Co.)
was added to a volume of 50 mL. After 15 minutes,
the leukocyte-rich supernatant was harvested and cen-
trifuged at 400g for 5 minutes at 4◦C. Residual erythro-
cytes were subjected to hypotonic lysis. This procedure
was repeated once or twice until the cell pellet was free
of erythrocytes. Cells were suspended in ice-cold PBS
and PMNL were counted using a standard hemocytome-
ter. The purity of the PMNL preparation was >95% and
viability >99% as judged by the trypan blue exclusion
method. PMNL were resuspended at 10 × 106 cells/mL
in Hank’s balanced salt solution (HBSS).
Measurement of superoxide production
Superoxide production by PMNL was determined by
measuring the capacity of cells to reduce ferricytochrome
to ferrocytochrome C [18]. PMNL aliquots of 125 lL
(1.25 × 106 cells) were incubated in EppendorfTM tubes
(USA/Scientific Plastic, Ocala, FL, USA) in the presence
of 25 lL of ferricytochrome C (12.3 mg/mL; Sigma Chem-
ical Co.), 25 lL of stimuli [10 nmol/L solution of 4-b
phorbol 12-b myristate 13-a-acetate (PMA) (Sigma
Chemical Co.)], or 10 lmol/L solution of N-formyl
methionyl-leucyl-phenylalanine (fMLP) (Sigma Chemi-
cal Co.) with and without 25 lL of superoxide dismutase
(SOD; 1 mg/mL; Sigma Chemical Co.). HBSS was added
to finalize the volume at 250 lL. After a 10-minute incu-
bation at 37◦C with rotational agitation, the tubes were
placed on ice and centrifuged at 14,000 rpm for 1 minute
at 4◦C. Control experiments were run in parallel using
25 lL of HBSS instead of stimuli. All experiments were
performed in duplicate. The amount of superoxide pro-
duced was quantitated by measuring the change in spec-
trophotometric absorbance of the cell-free supernatant at
dual wavelength (550 nm test filter with a reference wave-
length of 570 nm), using a microplate reader (MRX-500;
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Dynatech Laboratories, Inc., Chantilly, VA, USA). The
intra-assay coefficient of variation in our laboratory, for
measurement of stimulated superoxide production, was
<5% in 80% of samples and <10% in 100% of samples.
Results are expressed as nanomoles of superoxide pro-
duced/1.25 × 106 cells/10 minutes, based on an extinction
coefficient for a 1 cm light path (ferro-ferri) of 21.1.
Measurement of phagocytosis
A quantitative assay was used to determine the uptake
of opsonized 14C-labeled heat-killed S. aureus by phago-
cytes [18]. In brief, PMNL (500 lL = 5 × 106 cells) were
washed in PBS and resuspended in 800 lL of HBSS in a
12 × 75-mm polypropylene tube (Becton Dickinson Lab-
ware, Franklin Lakes, NJ, USA), in the presence of 100 lL
each of 14C-labeled S. aureus (5 × 107), and 10% autol-
ogous serum to make up a final volume of 1 mL. The
mixture was incubated at 37◦C for 30 minutes using rota-
tional agitation. The final bacteria-to-phagocyte ratio was
10:1. Phagocytosis was stopped by adding 2 mL of ice-cold
PBS to the mixture and the mixture was placed on ice for
2 minutes. Phagocyte-associated bacteria were separated
by centrifugation at 1200 rpm for 5 minutes. The super-
natant was aspirated to remove non-cell–associated bac-
teria. The pellet was resuspended in 2 mL of PBS. The
wash procedure was repeated twice and the cell pellet
finally suspended in 500 lL of 0.2N sodium hydroxide
solution and incubated overnight at 37◦C. To this was
added 200 lL of 3% acetic acid and 300 lL of HBSS.
The whole amount (1 mL) was aliquotted into a scintil-
lation tube, and 9 mL of scintillation liquid (EcoscintTM
H; National Diagnostics, Atlanta, GA, USA) was added.
Phagocyte-associated radioactivity was determined by a
1219 Rackbeta liquid scintillation counter (LK 66 Wallac;
Turku, Finland). Phagocytosis was expressed as an index:
ratio of cell associated counts/total radioactivity added
(estimated from the count on a vial containing 50 lL ra-
diolabeled bacteria and 10 mL of scintillation liquid).
Statistical analysis
Data definitions. Continuous clinical variables such
as serum albumin, age, and Kt/V, were divided into
quartiles and dichotomized around the 25th percentile.
Karnofsky score was also dichotomized around the 25th
percentile, the lowest quartile consisting of scores under
80. Patients with Index of Coexisting Diseases (ICED)
scores of 3 were categorized as having severe comor-
bidity as opposed to those with scores of 1 or 2 (mild
to moderate). A high-flux dialyzer was defined accord-
ing to the protocol of the HEMO study as one hav-
ing minimum values for ultrafiltration coefficient and
first-use b2-microglobulin clearance of 14 mL/hr/mm Hg
and 20 mL/min, respectively; a low-flux dialyzer was de-
fined as one having ultrafiltration coefficient and first-
use b2-microglobulin clearance values lower than these
[12]. Membrane type was classified as polysulphone (PS),
cuprophane (CU), or substituted cellulose (cellulose ac-
etate, cellulose triacetate, CA/CT). Germicidal agents
in reuse were categorized as aldehydes (formaldehyde,
glutaraldehyde) or renalin. Bleach-germicide combina-
tions formed three categories: bleach-aldehyde, bleach-
renalin, and renalin alone. HD adequacy was measured
by the equilibrated Kt/V (eKt/V) using the rate equation
of Daugirdas and Schneditz [19]. Vascular accesses were
categorized as native arteriovenous fistulae (AVF), grafts
(AVG), or venous catheters.
Analysis
Statistical analysis was carried out using a statistical
software program (SPSS for Windows, Release 10.1.0,
Chicago, IL, USA). Continuous data were expressed as
mean ± standard deviation and categorical data as pro-
portions; adjusted means were expressed as mean ± stan-
dard error of the mean (SEM).
Measures of PMNL function were used as outcome
variables (superoxide response to PMA and fMLP, and
% phagocytosis index). Because patient information and
PMNL function parameters were collated over a period
of 5.5 years (April 1995 to December 2000), all analy-
ses were adjusted for the year of enrollment to account
for evolution in practice patterns, standard of delivery of
dialysis care over this period of time, and any changes in
laboratory personnel and facilities. The association be-
tween measures of PMNL function and the following
independent variables were studied: dialyzer flux
(low- vs. high-flux), reuse-related variables such as the
cleansing agent (sodium hypochlorite or bleach) and ger-
micide, and dialysis adequacy (measured by eKt/V), using
a general linear model (GLM) adjusted for appropriate
factors and covariates. Measures of PMNL function in-
cluded superoxide response to PMA and fMLP, and the
% phagocytosis index. A P value of < 0.05 was consid-
ered statistically significant. The Bonferroni adjustment
was used for all multiple comparisons.
Hemodialysis practice patterns showed a change dur-
ing the 5-year period over which enrollment into the
HEMO study occurred, with a move to the almost
exclusive use of non-complement activating synthetic
membranes (PS) in the latter three years of the study.
fMLP-induced ROS production was studied only during
the latter three-year period in those patients exposed to
PS membranes. As membrane type and certain aspects of
reuse practice were colinear, analyses using appropriate
subsets were carried out.
The relationship between PMNL function and clinical
variables (ICED score and Karnofsky index) was also ex-
plored. The GLM was used to study PMNL responses in
patients at different levels of ICED or Karnofsky scoring.
Multivariate analysis using logistic regression and ICED
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Table 1. Baseline characteristics of the study population (N = 206)
Age years 61.9 ± 12.5
Male gender 45%
Race
Caucasian 55%
African American 45%
Number of years on dialysis 3.7 ± 4.3
<1 year 27%
1–3 years 36%
>3 years 37%
Cause of kidney failure
Diabetic nephropathy 34%
Hypertensive nephrosclerosis 32%
Glomerular disease 14%
Miscellaneous 20%
Percentage diabeticsa 42%
Body mass index kg/m2 24.7 ± 5.1
Serum albumin g/dL 3.6 ± 0.4
Hematocrit % 33.2 ± 5.0
Index of Coexistent Disease Scores (ICED)
1 34%
2 32%
3 34%
Karnofsky score 79.6 ± 17.1
Vascular access
AV fistula 78%
AV graft 14%
Venous catheter 8%
Equilibrated Kt/V 1.4 ± 0.2
nPCR, g/kg/day 1.0 ± 0.2
Data are expressed as mean ± SD or percentages.
aIncludes patients that had a diagnosis of diabetes even if diabetic nephropathy
was not the cause of ESRD.
score or Karnofsky index as response variables was per-
formed to study the effect of PMA- or fMLP-induced
superoxide responses, or% phagocytosis index. A model
was created with stepwise selection of the following co-
variates: year of enrollment, age, gender, race, and num-
ber of years spent on HD.
RESULTS
Baseline characteristics
A total of 210 patients were enrolled during the 5.5-
year period (April 1995 to December 2000) from the two
Boston centers participating in the HEMO Study. Table 1
shows baseline demographic, clinical, and selected labo-
ratory indices, as well as dialysis-related variables of 206
patients. There were 4 patients who were non-Caucasian
and non-African American and who were not consid-
ered for subsequent analysis. Sixty-nine percent of pa-
tients dialyzed with high-flux PS membranes, 10% of the
cohort, did not reuse dialyzers, chiefly where the patient
did not give consent for reuse. The distribution of mem-
brane type and flux in the present study reflected the
status at baseline before randomization to the high- or
low-flux limbs of the HEMO Study. Since much of this
data was obtained before the advent of automated re-
processing with renalin, the concomitant use of bleach
as a cleansing agent with renalin was still prevalent. In-
Table 2. Distribution of reuse by membrane type and flux property
Membrane N% Flux Reuse (N = 177) No reuse (N = 20)
CA/CT 12 (6%) Higha 8 0
Lowa 2 2
CU 20 (10%) High 0 0
Low 19 1
PS 165 (84%) High 132 14
Low 16 3
Data on reuse is missing in 9 patients. Abbreviations are: CA, cellulose
acetate; CT, cellulose triacetate; CU, cuprophane dialyzers; PS, polysulfone
dialyzers.
aCA, cellulose acetate, classified as low flux; CT, cellulose triacetate, classified
as high flux.
deed, bleach was the cleansing agent in 95.5% of dialyz-
ers, with either formaldehyde or glutaraldehyde as the
germicidal agent in 37%, and renalin in 58%. Tables 2
and 3 show the distribution of reuse and related param-
eters by membrane type and flux property. The effect
of flux on PMNL function was assessed only in PS and
CA/CT, as all cuprophane (CU) dialyzers were low-flux
membranes. The effect of germicidal agent (aldehyde vs.
renalin) was assessed only in reused CU and PS dialyzers,
as nine of 10 reused CA/CT dialyzers were sterilized with
glutaraldehyde.
Superoxide production in study and control population
Superoxide production (mean ± SEM) by PMNLs har-
vested from 10 healthy individuals was 52.0 ± 4.3 nmol
O2−/1.25 × 106 cells/10 minutes after stimulation with
PMA and 19.0 ± 4.0 nmol O2−/1.25 × 106 cells/10 min-
utes after stimulation with fMLP. The corresponding un-
adjusted values for HD patients in this cohort were 32.4 ±
0.9 nmol O2−/1.25 × 106 cells/10 minutes and 22.0 ±
1.5 nmol O2−/1.25 × 106 cells/10 minutes, respectively.
PMA-induced superoxide production was significantly
lower in HD patients (P < 0.001); the difference for
fMLP-induced superoxide production between HD and
healthy controls did not reach significance.
Dialysis- and reuse-related factors associated
with PMNL function
Tables 4 and 5 show the relationship between dialysis-
and reuse-associated variables and measures of PMNL
function adjusted for year of enrollment.
PMA-induced superoxide production by PMNL
Effect of membrane. PMNL from patients dialyzed
with either PS or CU membranes demonstrated higher
respiratory burst activity in response to PMA in com-
parison to those exposed to CA/CT membranes (33.3 ±
0.7, 31.1 ± 2.0 vs. 21.5 ± 2.6; P < 0.001 for PS vs. CA/CT,
P = 0.01 for Cu vs. CA/CT, P = NS for PS vs.Cu)
(Table 4). These differences in PMA-induced superoxide
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Table 3. Distribution of type of cleansing agent and germicide utilized for reprocessing dialyzers by membrane type and flux property (N = 177)
Cleansing agent and germicide
Membrane N% Flux Bleach + aldehydeb Bleach + glutaraldehydeb Bleach + renalin Renalin only
CA/CT 10 (6%) Higha 0 7 0 0
Lowa 0 2 0 1
CU 19 (11%) High 0 0 0 0
Low 1 15 2 1
PS 148 (83%) High 12 26 88 6
Low 1 2 13 0
Abbreviations are: CA, cellulose acetate; CT, cellulose triacetate; CU, cuprophane dialyzers; PS, polysulfone dialyzers.
aCA, cellulose acetate, classified as low flux; CT, cellulose triacetate, classified as high flux.
bBoth formaldehyde and glutaraldehyde treatment considered for analysis as a single category.
Table 4. Association between dialysis- and reuse-associated variables and PMNL superoxide production and % phagocytosis index
PMNL superoxide production
(nmol O 2−/1.25 × 106 cells/10 min)
PMA FMLP Phagocytosis
N responsea P N responsea P value N index (%)a P value
Healthy control 10 52.0 ± 4.3 10 19.0 ± 1.6
All patients 205 32.3 ± 0.7 65 22.3 ± 1.6 203 44.2 ± 1.1
PMNL function by membraneb
CA/CT 12 21.5 ± 2.6 12 46.0 ± 3.4 0.3
CU 21 31.1 ± 2.0 <0.001 21 37.8 ± 4.4
PS 172 33.3 ± 0.7 65 22.3 ± 1.6 170 44.5 ± 1.2
PMNL function by reuse
No 20 29.4 ± 2.1 0.3 13 15.8 ± 3.5 0.04 19 40.7 ± 3.6 0.3
Yes 176 31.9 ± 0.7 46 24.4 ± 1.9 175 44.4 ± 1.1
PMNL function by dialysis adequacy
Kt/V Q-1 (<1.28; range 0.95–1.27) 51 33.8 ± 1.3 0.2 16 22.9 ± 3.3 0.8 56 44.8 ± 2.2 0.9
Kt/V Q2-4 (≥1.28; range 1.28–1.97) 154 31.9 ± 0.8 49 22.1 ± 1.8 147 44.1 ± 1.2
PMNL function by number of years on dialysis
≤1 year 56 34.4 ± 1.2 0.05 19 19.9 ± 2.9 0.3 49 44.5 ± 2.0 0.8
>1 year 149 31.6 ± 0.8 46 23.3 ± 1.9 154 44.1 ± 1.3
PMNL function by flux property
Patients using CA/CT or PS dialyzers 184 33.0 ± 0.7 182 33.0 ± 0.7 182 33.0 ± 0.7
Low-flux 35 33.4 ± 1.7 0.8 25 19.3 ± 2.5 0.1 35 46.3 ± 2.8 0.4
High-flux 149 33.0 ± 0.8 40 24.2 ± 2.0 147 43.5 ± 1.5
PMNL function by cleansing agent-germicide categories
Patients reusing CU or PS dialyzers 166 31.5 ± 0.7 46 24.5 ± 2.0 165 44.7 ± 1.2
Bleach + aldehydec 57 29.9 ± 1.1 0.003d 6 25.0 ± 6.5 0.9 57 41.5 ± 2.0
Bleach +renalin 102 33.1 ± 0.8 34 24.5 ± 2.5 101 45.7 ± 1.5 0.05e
Renalin alone 7 23.0 ± 3.5 6 21.9 ± 5.7 7 56.7 ± 6.3
Abbreviations are: CA, cellulose acetate; CT, cellulose triacetate; CU, cuprophane dialyzers; PS, polysulfone dialyzers. fMLP-induced responses were only studied in
65 patients using PS dialyzers. PMA-induced responses were available in 205 patients; % phagocytosis index was available in 203 patients; reuse data was not available
in 9 patients.
aAdjusted for year of enrollment; P < 0.001 in models for PMA-induced superoxide response as outcome.
bPS vs. CA/CT: P < 0.001; CU vs. CA/CT: P = 0.01; PS vs. CU: P = NS.
cAldehyde includes formaldehyde or glutaraldehyde.
dRenalin alone vs. bleach + renalin: P = 0.006; bleach + renalin vs. bleach + aldehyde: P = 0.03.
eRenalin alone vs. bleach + renalin: P = 0.09; bleach + renalin vs. bleach + aldehyde: P = 0.09; renalin alone vs. bleach + aldehyde: P = 0.03.
production between CA/CT and either CU or PS mem-
branes remained significant (P < 0.001), after further ad-
justment for Kt/V, number of years spent on HD, and
reuse. Of these covariates, number of years spent on
HD showed a significant inverse relationship with PMA-
induced superoxide production.
Effect of flux. The effect of flux on PMA-induced
superoxide production was studied in CA/CT and PS
membranes. On adjustment for year of enrollment alone
(Table 4), as well as further adjustment for membrane
type, reuse, Kt/V, and number of years spent on HD,
there was no significant difference in PMA-induced
superoxide production between high- and low-flux dialyz-
ers. However, PMA-induced superoxide production re-
mained significantly higher in PMNL from patients using
PS dialyzers compared to CA/CT dialyzers (P < 0.001), as
demonstrated in the preceding section. Other variables—
number of years spent on HD, dialyzer reuse, and
eKt/V—showed no significant association with PMA-
induced respiratory burst.
Effect of membrane and flux. High- and low-flux
membranes were analyzed as separate strata. Fifty-six
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Table 5. Multivariate analysis (multiple linear regression) to show
the effect of dialysis- and reuse-associated variables on
fMLP-stimulated superoxide production by PMNL among patients
using PS dialyzers (N = 65)
Parameter 95% CI
Variable estimate (PE) for PE P value
Dialzyer reuse (vs. single use) 9.1 0.8–17.4 0.03
No. of years on 0.1 −0.6–0.9 0.7
dialysis (per year)
Kt/V (per 1.0 increase) 8.9 −11.4–29.3 0.4
Adjusted for year of enrollment (P = NS).
patients used low-flux membranes (CA = 4, CU = 21,
and PS = 31), and 150 patients used high-flux mem-
branes (8 CT and 142 PS). In the high-flux category, PMA-
induced superoxide production was significantly lower
in CT membranes compared with PS on adjustment for
Kt/V, number of years spent on HD, and reuse (19.2 ±
3.0 vs. 31.0 ± 0.7; P < 0.001). In the low-flux category,
the difference in PMA-induced superoxide production
remained significant across membrane type (CA, CU, PS:
23.6 ± 5.2, 30.8 ± 2.9, 39.5 ± 2.3; P = 0.03). The com-
parison between CA and CU was significant (P = 0.01),
although that between PS and CU was not (P = 0.06).
Stratification by membrane type showed no difference
in PMA-induced superoxide production between high-
and low-flux substituted cellulose membranes (CA vs.
CT), or between high- and low-flux PS membranes (data
not shown).
Effect of the three cleansing agent-germicide categories
(bleach + aldehyde, bleach + renalin, renalin alone).
This was studied in either CU or PS reused dialyzers.
There were only 7 dialyzers reprocessed with renalin
alone, without the concomitant use of bleach as a cleans-
ing agent. However, the use of renalin alone was asso-
ciated with significantly lower PMA-induced superoxide
production compared with dialyzers in which both re-
nalin and bleach were used (23.0 ± 3.5 vs. 33.1 ± 0.8;
P = 0.006), or compared with dialyzers reprocessed with
aldehydes and bleach (23.0 ± 3.5 vs. 29.9 ± 1.1; P = 0.03)
(Table 4). These differences persisted when the effect of
the bleach-germicide categories was further adjusted for
Kt/V, number of years spent on HD, and membrane type
(renalin alone vs. bleach + renalin: 24.5 ± 3.6 vs. 32.9 ±
0.9; P = 0.02; bleach + aldehyde vs. bleach + renalin:
29.9 ± 1.2 vs. 32.9 ± 0.9; P = 0.05). Of the above covari-
ates, number of years spent on HD showed an inverse
relationship with PMA-induced superoxide production
(P = 0.02).
Effect of number of years spent on HD. Patients who
had been on HD <1 year had higher respiratory burst
activity in response to PMA in comparison to those on
HD >1 year (34.4 ± 1.2 vs. 31.6 ± 0.8; P = 0.05). As
demonstrated in the earlier adjusted analyses for effects
of membrane, flux and bleach-sterilant combinations, re-
spectively, number of years spent on HD used as a covari-
ate, showed an inverse relationship with PMA-induced
superoxide production. The relationship was significant
when all patients were studied (parameter estimate, PE =
−0.3, P = 0.03), the model being adjusted for membrane
type, Kt/V, and reuse. Similar analysis of the subset of pa-
tients reusing CU or PS dialyzers, adjusted for membrane
type, bleach-germicide combination, and Kt/V were stud-
ied, showed an inverse relationship between number of
years spent on HD and PMA-induced superoxide pro-
duction (PE = −0.3, P = 0.02). Thus, each additional year
on dialysis was associated with a decline in PMA-induced
superoxide production roughly the magnitude suggested
by the respective coefficients. Indeed, when patients were
categorized by duration on HD of <1 year, 1 to 3 years,
and >3 years, a graded decrease in the level of PMA-
induced superoxide production was apparent (34.4 ± 1.2,
33.0 ± 1.1, 30.2 ± 1.1; P = 0.03). When only the subset of
patients using CA/CT or PS dialyzers was analyzed, after
adjustment for membrane flux there was a trend toward
an inverse relationship between PMA-induced superox-
ide production and number of years spent on HD (PE =
−0.3; P = 0.07).
Stratification for flux property showed that the inverse
relationship between PMA-induced superoxide produc-
tion and number of years spent on HD remained signifi-
cant in high-flux dialyzers (PE = −0.4; P = 0.03), but not
when only low-flux dialyzers were considered.
fMLP-induced superoxide production by PMNL
among patients using PS dialyzers
Reuse was associated with significantly higher fMLP-
stimulated superoxide production (24.4 ± 1.9 vs. 15.8
± 3.5 for patients not reusing, P = 0.04) in 65 patients
using PS dialyzers (Table 4). This difference remained
significant (P = 0.03) after further adjustment for Kt/V
and number of years spent on HD (Table 5). The model
was not adjusted for flux, because all high-flux PS di-
alyzers and about half the low-flux PS dialyzers were
reused. When the effect of reuse was assessed in only
the subset of patients using low-flux dialysers, the asso-
ciation with higher fMLP-stimulated superoxide produc-
tion did not reach statistical significance (23.2 ± 3.1 vs.
15.5 ± 3.0 for patients not reusing, P = 0.09). Further,
the model also showed that the flux property of the di-
alyzer and bleach-germicide combination did not influ-
ence fMLP-stimulated superoxide production. This was
also true when the subset of reused PS dialyzers were
considered.
% Phagocytosis index
No association was demonstrable between membrane
type, flux, or reuse, and % phagocytosis index. How-
ever, in those patients reusing (i.e., either CU or PS
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membranes), the % phagocytosis index was significantly
different in the three bleach-germicide categories, being
highest with the use of renalin alone, followed by bleach+
renalin and then bleach + aldehyde (P = 0.05). The dif-
ference between renalin alone versus bleach + renalin,
and bleach + renalin versus bleach + aldehyde did not
reach statistical significance (P = 0.09), whereas use of
renalin alone versus bleach + aldehyde was significantly
different (P = 0.03) (Table 4). On further adjustment for
Kt/V, number of years spent on HD, and membrane type
as covariates, the differences among the three bleach-
germicide categories remained significant (P = 0.05). The
use of renalin alone was associated with a higher% phago-
cytosis index than bleach + aldehyde (55.8 ± 6.5 vs. 41.2 ±
2.1; P = 0.04). While the use of bleach + renalin showed
higher % phagocytosis index than bleach + aldehyde, this
did not reach statistical significance (46.0 ± 1.6 vs. 41.2 ±
2.1; P = 0.08). The difference between use of renalin
alone versus bleach + renalin did not reach statistical
significance.
“Center effects”
Patients enrolled from a total of 10 dialysis units. Uni-
variate analysis showed that significant differences in
PMA-induced superoxide production (P < 0.001), and
phagocytosis index (P = 0.05) existed among patients
drawn from different units, although fMLP-induced su-
peroxide production did not show a difference. This was
attributable to the significant differences in dialysis- and
reuse-related factors among these units. The type of
membrane used differed: six units used exclusively PS
membranes; at least two units did not practice reuse;
and in those that did, at least three units used only a
renalin-bleach combination, and two an aldehyde-bleach
combination. As the dialysis unit appeared to cosegre-
gate almost completely with one or more dialysis- or
reuse-related factor, is was not included in multivariate
adjustments.
Patient-related factors and clinical comorbidity
associated with PMNL function
PMA-induced superoxide production by PMNL and
patient related factors. PMA-induced superoxide pro-
duction did not differ by age, gender, race, presence of
diabetes, or type of vascular access. All analyses were ad-
justed for the year of enrollment into the study.
fMLP-induced superoxide production by PMNL and
clinical comorbidity. fMLP-induced superoxide pro-
duction was found to be significantly higher in African
American than Caucasian subjects (27.9 ± 2.1 vs. 17.2 ±
2.0; P < 0.001), and marginally higher in female subjects
(24.0 ± 1.9 vs. 18.2 ± 2.9 in males; P = 0.09). There was
no relationship to age or number of years spent on HD.
Patients dialyzing through AVG had the highest levels of
fMLP-induced superoxide production, followed by pa-
tients dialyzing through AVF, with the lowest levels seen
in patients with venous catheters (34.8 ± 4.1, 21.0 ± 1.7,
15.6 ± 4.8; P = 0.005). Patients with the highest ICED
score showed significantly lower levels of fMLP-induced
superoxide production by PMNL (17.2 ± 2.8 in patients
with ICED score of 3 vs. 24.6 ± 1.8 in patients with ICED
score of 1 or 2; P = 0.03). Similarly, fMLP-induced su-
peroxide production by PMNL was lower in patients in
the lowest quartile of Karnofsky scores, consisting of pa-
tients with scores of 40–70 (Q 1), versus those with scores
of ≥80 (Q 2–4) (16.3 ± 2.9 in Q 1 vs. 24.6 ± 1.8 in Q 2–4;
P = 0.02).
Multivariate analysis using logistic regression identi-
fied higher fMLP-induced superoxide production as the
only significant factor associated with lower odds of the
outcome of highest ICED score of 3 (OR = 0.94, 95%
CI = 0.89–0.99; P = 0.03). Other independent variables
that were not significant included year of enrollment, age,
gender, race, and number of years spent on HD. When
being in the lowest quartile of Karnofsky scoring was con-
sidered as the outcome variable, the significant variables
in the equation were fMLP-induced superoxide produc-
tion (OR = 0.91, 95% CI = 0.85–0.98; P = 0.007), age
(OR = 1.07, 95% CI = 1.01–1.15; P = 0.04), and race
(Caucasian vs. African American: OR = 0.24, 95% CI =
0.06–0.95; P = 0.04). The year of enrollment, gender, and
number of years spent on HD were not significantly as-
sociated with the outcome.
% Phagocytosis index did not show any relationship to
clinical or demographic parameters.
DISCUSSION
Bacterial infections are a frequent cause of morbid-
ity and mortality in patients with end-stage renal disease
(ESRD) on maintenance dialysis, and most studies indi-
cate they are the second leading cause of death in this
patient population [20]. PMNL are an integral compo-
nent of host defense against bacterial infections, and there
is substantial clinical evidence that indicates profound
disturbances in PMNL function in patients on chronic
hemodialysis. Impaired chemotaxis, phagocytic capacity,
bactericidal activity, and metabolic dysfunction of these
cells in HD patients have been reported [21]. Mech-
anisms ascribed to altered PMNL function in uremia
include malnutrition, iron overload, and increased intra-
cellular calcium [22]. In the present study, we examined
the relationship of dialysis-related, as well as other clin-
ical variables, to PMNL function in a cohort of patients
with ESRD on long-term maintenance hemodialysis en-
rolled in the National Institutes of Health-sponsored
HEMO Study.
Our results showed that use of synthetic dialyzer mem-
branes (PS) and CU membranes were associated with
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higher PMA-stimulated respiratory burst than CA/CT
membranes. The flux property of the membrane did not
appear to be important in influencing the PMNL func-
tional parameters measured. While a difference between
fMLP-induced superoxide production was demonstrable
between reused and single-use PS dialyzers, we were
unable to show a similar difference in PMA-induced
superoxide production or the % phagocytosis index.
However, when only reused dialyzers were analyzed, the
use of bleach and renalin combination appeared to be
associated with higher PMA-induced superoxide produc-
tion, and the use of renalin alone with higher% phagocy-
tosis index. In addition, there was also a significant inverse
relationship between the number of years spent on HD
and PMA-induced superoxide production, especially in
high-flux dialyzers. Therefore, dialyzer membrane type
(CA/CT vs. CU or vs. PS membranes), dialyzer repro-
cessing, and the number of years on HD influence PMNL
function in patients on maintenance HD.
There is only limited information on the long-term im-
pact of dialyzer membrane biocompatibility on PMNL
function. Previous studies indicate that PMNL exposed
to complement-activating dialyzer membranes generate
ROS during dialysis [23]. Studies utilizing ex vivo models
of hemodialysis have demonstrated significant priming
of PMNL respiratory burst by CU, but not PS dialyzer
membranes [24]. In the present study, patients dialyz-
ing with CU membranes showed higher PMA responses
compared to those dialyzing with substituted CA/CT
membranes. Intradialytic generation of ROS has been
observed 15 minutes after initiation of hemodialysis with
CU membranes. These cells, however, become refractory
to subsequent stimulation by complement products and
fMLP [23]. Vanholder et al [11] studied the metabolic re-
sponse of PMNL (glucose-1-C14 utilization in response
to latex and zymosan) sequentially in a small cohort of
patients with ESRD initiated on maintenance HD. In
contrast to synthetic membranes (PS and polymethyl-
methacrylate), initiation of dialysis with an unsubstituted
cellulose membrane (CU) led to a sharp decline in the
metabolic response of these cells to phagocytic challenge
after four weeks of hemodialysis. Further, this attenu-
ated metabolic response was reversed after two weeks of
hemodialysis with a synthetic membrane [11]. The abnor-
mal response of PMNL exposed to CU membranes was
believed to be related to a state of “deactivation” arising
from recurrent complement activation and subsequent
intradialytic PMNL stimulation. Over time, these cells
could become relatively refractory to further challenge,
particularly during the interdialytic period [25]. These lat-
ter observations are at variance with our data, as higher
ROS production was still demonstrable with chronic use
of CU membranes compared to CA/CT membranes.
Our observations were based on the small proportion of
patients who dialyzed with CU (20/206), were not sequen-
tial, and were drawn on patients who had been on long-
term maintenance dialysis. However, a stratified analysis
did suggest lower PMNL oxidative response to PMA with
CU membranes compared to low-flux PS membranes.
Among the many partly interdependent factors con-
tributing to PMNL dysfunction in advanced uremia, cer-
tain middle molecular weight uremic toxins appear to
play an important role [22]. Plasma levels of many of
these peptides, such as granulocyte inhibitory protein
I and II, degranulation inhibiting protein I (identical
to angiogenin), and degranulation inhibiting protein II
(complement factor D), are markedly elevated in ESRD
patients and interfere with several facets of PMNL func-
tion, including chemotaxis, oxidative response to PMA,
and fMLP and bactericidal activity [21, 22]. High-flux syn-
thetic dialyzers (PS and AN69) have been shown to pro-
duce significant reduction in plasma levels of these middle
molecular weight proteins [21]. While bioincompatibility
could explain the higher oxidative response seen with CU
membranes, more effective clearance of middle molecu-
lar weight proteins may explain that observed with PS
membranes in this study.
The influence of dialyzer reprocessing on PMNL func-
tion has not been previously reported. We observed a
relationship between reuse and associated variables and
enhanced PMNL response to PMA and fMLP, as well as
phagocytosis. Recent data from the Hemodialysis Study
Group showed increased middle molecule clearance of
synthetic membranes after reuse with bleach, particularly
for high-flux PS membranes [26]. Other studies have indi-
cated that high-flux dialyzer membranes reprocessed with
renalin show a reduction in clearance of b2-microglobulin
[27]. However, in the present study, for the majority of
patients using dialyzers reprocessed with renalin, bleach
was utilized as a cleansing agent (Table 3). It is possible
that a reuse procedure that improves dialyzer flux prop-
erty may result in improved clearance of these PMNL
inhibitory proteins and consequently lead to improved
PMNL functional response. On the other hand, there
have been a few large representative cohort studies link-
ing reuse with infection risk, and enhanced PMNL func-
tional response with reuse may reflect PMNL priming
by bacterial products. In a longitudinal cohort study of
incident ESRD patients in the case-mix study of the US-
RDS, Powe et al [28] observed that patients who reused
had a 28% higher risk of septicemia than patients who
did not reuse dialyzers over the entire follow-up period
of seven years. However, the relative effects of specific
sterilants or bleach were not evaluated in this study. In-
deed, in the USRDS Dialysis Morbidity and Mortality
Study, Port et al [29] observed substantially lower mortal-
ity for synthetic dialyzers treated with bleach compared
with no bleach during the reuse procedure. To date, few
clinical studies have investigated the influence of dialyzer
biocompatibility on susceptibility to bacterial infections.
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Two studies have shown lower infective morbidity with
PS dialyzers compared to CU dialyzers [11]. The clinical
impact of dialyzer membrane type and reuse associated
effects on PMNL function requires further elucidation.
It is therefore apparent that several mechanisms,
including biocompatibility, middle molecule clearance,
neutrophil priming by bacterial products, and develop-
ment of a relative refractoriness to oxidant stress over
time may all impact on PMNL oxidative response. The
association between decrease in PMA-induced superox-
ide production, especially in high-flux dialyzers, and num-
ber of years spent on HD may therefore reflect interplay
between any of the above factors and will be difficult
to resolve in a cross-sectional study. Previous work from
this center demonstrated an inverse correlation between
cytokine (interleukin-1 receptor antagonist) synthesis by
peripheral blood mononuclear cells (PBMC) and num-
ber of years spent on HD [30]. These observations may
be an indication of impaired host defense mechanisms
in patients on long-term HD, and prospective outcome-
related evaluation is required to study this further.
We also observed a strong relationship between lower
response of PMNLs to fMLP, and worse comorbidity in
terms of higher ICED scores and lower Karnofsky in-
dices. These associations remained significant even after
adjustment for age, gender, race, and duration spent on
HD, indicating a link between diminished PMNL respira-
tory burst activity and chronic comorbidity in long-term
HD patients. However, due to the cross-sectional nature
of this study, a causal relationship cannot be inferred.
Further, our observation that African American subjects
showed an enhanced response of PMNL to fMLP is con-
sistent with previous observations that African American
patients on HD have lower infection-related mortality
compared to Caucasians [20]. It is also significant that
patients dialyzing off venous catheters had lower levels
of fMLP-induced superoxide production, considering the
higher risks of infection with this access type.
There are several limitations in this study that require
mention. First, it is cross-sectional and observational;
hence, inferences can only be drawn regarding associa-
tions between PMNL function and explanatory variables
addressed in the study. Second, being ancillary to the
HEMO Study, patient selection and design could not be
controlled to answer specific questions related to PMNL
function. Specifically, information regarding characteris-
tics of reuse practice, differences between facilities, and
duration of exposure to a particular dialyzer cleansing or
germicidal agent may have had an impact on the relation-
ship between reuse and PMNL function, and could not
be accounted for in the analysis. Although there were sig-
nificant associations between the individual dialysis unit
and PMNL function, the “Center effect” could not be
dissociated from other dialysis- and reuse-related factors
because of practice differences. Further, HEMO Study
participants represented a very select population with
predominantly prevalent patients (average duration on
HD >3years), and the results may not be easily gener-
alizable. Finally, while we were able to demonstrate re-
lationships between diminished PMNL ROS production
and more severe comorbidity, the ability to interpret the
clinical significance of changes in PMNL ROS production
is limited.
CONCLUSION
Clearly, our observations on the association of mem-
brane biocompatibility and reuse characteristics with
PMNL function, as well as the association with comor-
bidity indices, require confirmation in a prospective study.
This is currently in progress with our cohort of patients
enrolled in the Hemodialysis Study.
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